These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 466893)

  • 1. The effect of chemotherapy on pituitary function in patients with advanced breast cancer.
    McFadyen IJ; Raab G; Cant E; Forrest AP; Groom GV; Griffiths K
    Clin Oncol; 1979 Jun; 5(2):153-7. PubMed ID: 466893
    [No Abstract]   [Full Text] [Related]  

  • 2. Pituitary function and clinical response in breast cancer patients after yttrium implantation.
    McFadyen IJ; Raab G; Buchan R; Forrest AP; Golder MP; Groom GV; Griffiths K
    Clin Oncol; 1979 Mar; 5(1):33-41. PubMed ID: 421386
    [No Abstract]   [Full Text] [Related]  

  • 3. Anterior pituitary function following hypophysectomy for breast cancer.
    Fairney A; Morgan L; Barrett A; de Souza I; Barnes G
    Clin Oncol; 1976 Jun; 2(2):121-6. PubMed ID: 821686
    [No Abstract]   [Full Text] [Related]  

  • 4. Pituitary function tests in patients with Sheehan's syndrome.
    Rajatanavin R; Pitchayayothin N; Namking M; Pavasuthipaisit K; Himathongkam T
    J Med Assoc Thai; 1988 Aug; 71(8):443-50. PubMed ID: 2855234
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of pituitary function.
    Blackwell RE; Younger JB
    Obstet Gynecol Annu; 1981; 10():349-61. PubMed ID: 6269036
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pituitary hormone level in breast cancer patients].
    Agranat VZ; Valiura AV; Nikogosian GA
    Med Radiol (Mosk); 1981 Mar; 26(3):3-8. PubMed ID: 6783807
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudocyesis: pituitary function before and after resolution of symptoms.
    Tulandi T; McInnes RA; Mehta A; Tolis G
    Obstet Gynecol; 1982 Jan; 59(1):119-21. PubMed ID: 6804895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin F2alpha: effect on cortisol, growth hormone, luteinizing hormone, follicle-stimulating hormone, prolactin and thyroid-stimulating hormone.
    Vanderheyden K; Dhont M; Vandekerckhove D; Vermeulen A; Thiery M
    ICRS J Int Res Commun; 1974 Mar; 2(3):1164. PubMed ID: 4469240
    [No Abstract]   [Full Text] [Related]  

  • 9. L-Dopa effect on prolactin, follicle-stimulating hormone, and luteinizing hormone in women with advanced breast cancer: a preliminary report.
    Dickey RP; Minton JP
    Am J Obstet Gynecol; 1972 Sep; 114(2):267-9. PubMed ID: 4635766
    [No Abstract]   [Full Text] [Related]  

  • 10. Relation between endocrine function and survival of patients with breast cancer after hypophysectomy.
    Wang DY; Bulbrook RD; Rubens RD; Bates T; Knight RK; Hayward JL
    Clin Oncol; 1979 Dec; 5(4):311-6. PubMed ID: 160296
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between thyroid-pituitary function and response to therapy in patients with recurrent breast cancer.
    Yokoe T; Iino Y; Takei H; Horiguchi J; Koibuchi Y; Maemura M; Ohwada S; Morishita Y
    Anticancer Res; 1996; 16(4A):2069-72. PubMed ID: 8712744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Buserelin therapy in postmenopausal patients with advanced breast carcinoma].
    Vici P; Veltri E; Carpano S; Di Lauro L; Lopez M
    Clin Ter; 1991 Feb; 136(3):195-9. PubMed ID: 1827382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of LH-RH agonists on the growth and hormonal environment of breast and prostate cancer.
    Nicholson RI; Walker KJ
    Chemioterapia; 1985 Jun; 4(3):249-51. PubMed ID: 3161643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary function in 8 patients with familial pituitary dwarfism.
    Batrinos ML; Pitoulis SA; Anousakis CT; Koutsilieris MN; Panitsa-Faflia C; Orphanos ST
    Helv Paediatr Acta; 1981 Nov; 36(5):417-27. PubMed ID: 6273366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay of anterior pituitary hormones.
    Selenkow HA; Wool MS; Refetoff S
    Radiol Clin North Am; 1967 Aug; 5(2):317-31. PubMed ID: 4317743
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endocrine diagnosis of pituitary adenomas (author's transl)].
    Nakai Y; Oki S; Nakao K; Fukada J; Kinoshita F; Tanaka K; Tsukada T; Imura H
    No To Shinkei; 1981 May; 33(5):431-40. PubMed ID: 6266437
    [No Abstract]   [Full Text] [Related]  

  • 18. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.
    Jordan VC; Fritz NF; Tormey DC
    Cancer Res; 1987 Jan; 47(2):624-30. PubMed ID: 3098415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acute effect of 2-bromo-a-ergocryptine (CB-154) on anterior pituitary hormones and free fatty acids in man.
    Tolis G; Pinter EJ; Friesen HG
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):281-3. PubMed ID: 1165136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients.
    Bhatavdekar JM; Patel DD; Shah NG; Giri DD; Vora HH; Karelia NH; Trivedi SN; Ghosh N; Suthar TP
    Neoplasma; 1992; 39(1):39-42. PubMed ID: 1388248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.